Your browser doesn't support javascript.
loading
Trends in All-Cause, Cardiovascular, and Noncardiovascular Mortality Among US Adults With Hypertension.
Choi, Eunhee; Shimbo, Daichi; Chen, Ligong; Foti, Kathryn; Ghazi, Lama; Hardy, Shakia T; Muntner, Paul.
Afiliação
  • Choi E; Columbia Hypertension Laboratory, Department of Medicine, Columbia University Irving Medical Center, New York, NY (E.C., D.S.).
  • Shimbo D; Columbia Hypertension Laboratory, Department of Medicine, Columbia University Irving Medical Center, New York, NY (E.C., D.S.).
  • Chen L; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL (L.C., K.F., L.G., S.T.H., P.M.).
  • Foti K; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL (L.C., K.F., L.G., S.T.H., P.M.).
  • Ghazi L; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL (L.C., K.F., L.G., S.T.H., P.M.).
  • Hardy ST; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL (L.C., K.F., L.G., S.T.H., P.M.).
  • Muntner P; Department of Epidemiology, University of North Carolina at Chapel Hill, NC (S.T.H.).
Hypertension ; 81(5): 1055-1064, 2024 May.
Article em En | MEDLINE | ID: mdl-38390740
ABSTRACT

BACKGROUND:

Death certificate data indicate that hypertension may have increased as a contributing cause of death among US adults. Hypertension is not commonly recorded on death certificates although it contributes to a substantial proportion of cardiovascular disease (CVD) deaths.

METHODS:

We estimated changes in all-cause, CVD, and non-CVD mortality over 5 years of follow-up among 4 cohorts of US adults with hypertension using mortality follow-up data from National Health and Nutrition Examination Survey III in 1988 to 1994, and National Health and Nutrition Examination Survey cycles from 1999 to 2000 through 2015 to 2016 (n=20 927). Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or antihypertensive medication use. Participants were grouped according to the date of their National Health and Nutrition Examination Survey study visit (1988-1994, 1999-2004, 2005-2010, 2011-2016).

RESULTS:

There were 2646, 1048, and 1598 all-cause, CVD, and non-CVD deaths, respectively. After age, gender, and race/ethnicity adjustment and compared with the 1988 to 1994 cohort, the hazard ratio of all-cause mortality was 0.88 (95% CI, 0.76-1.01) for the 1999 to 2004 cohort, 0.82 (95% CI, 0.70-0.95) for the 2005 to 2010 cohort, and 0.89 (95% CI, 0.75-1.05) for the 2011 to 2016 cohort (P trend=0.123). The age, gender, and race/ethnicity-adjusted hazard ratios for CVD mortality compared with the 1988 to 1994 cohort were 0.74 (95% CI, 0.60-0.90) for the 1999 to 2004 cohort, 0.61 (95% CI, 0.50-0.74) for the 2005 to 2010 cohort, and 0.57 (95% CI, 0.44-0.74) for the 2011 to 2016 cohort (P trend <0.001). There was no evidence of a change in CVD mortality between the 2005 to 2010 and 2011 to 2016 cohorts (P=0.661). Noncardiovascular mortality did not decline over the study period (P trend=0.145).

CONCLUSIONS:

The decline in CVD mortality among US adults with hypertension stalled after 2005 to 2010.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Limite: Adult / Humans Idioma: En Revista: Hypertension Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Limite: Adult / Humans Idioma: En Revista: Hypertension Ano de publicação: 2024 Tipo de documento: Article